

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | hemidesmosome assembly (GO:0031581) | 8.77130848 |
| 2 | regulation of water loss via skin (GO:0033561) | 7.60851068 |
| 3 | establishment of skin barrier (GO:0061436) | 7.49125581 |
| 4 | interferon-gamma secretion (GO:0072643) | 6.05911720 |
| 5 | keratinocyte proliferation (GO:0043616) | 5.91433867 |
| 6 | keratinocyte differentiation (GO:0030216) | 5.52949046 |
| 7 | keratinization (GO:0031424) | 5.41146087 |
| 8 | multicellular organismal water homeostasis (GO:0050891) | 5.30449162 |
| 9 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 4.84694023 |
| 10 | molting cycle (GO:0042303) | 4.59647395 |
| 11 | hair cycle (GO:0042633) | 4.59647395 |
| 12 | negative regulation of keratinocyte proliferation (GO:0010839) | 4.52522062 |
| 13 | epidermal cell differentiation (GO:0009913) | 4.42886851 |
| 14 | water homeostasis (GO:0030104) | 4.38597603 |
| 15 | intestinal epithelial cell development (GO:0060576) | 4.27957176 |
| 16 | regulation of chemokine secretion (GO:0090196) | 4.10345366 |
| 17 | surfactant homeostasis (GO:0043129) | 4.04163498 |
| 18 | skin morphogenesis (GO:0043589) | 3.92799218 |
| 19 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 3.83765881 |
| 20 | activation of MAPKKK activity (GO:0000185) | 3.79033139 |
| 21 | ectoderm development (GO:0007398) | 3.71546492 |
| 22 | keratinocyte development (GO:0003334) | 3.71179317 |
| 23 | sphingoid metabolic process (GO:0046519) | 3.69537740 |
| 24 | intermediate filament organization (GO:0045109) | 3.63505727 |
| 25 | negative regulation of stress fiber assembly (GO:0051497) | 3.52110640 |
| 26 | peptide cross-linking (GO:0018149) | 3.51964426 |
| 27 | adhesion of symbiont to host cell (GO:0044650) | 3.50306468 |
| 28 | virion attachment to host cell (GO:0019062) | 3.50306468 |
| 29 | epidermis development (GO:0008544) | 3.49943834 |
| 30 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 3.47811161 |
| 31 | sphingosine metabolic process (GO:0006670) | 3.44026546 |
| 32 | protein localization to endosome (GO:0036010) | 3.38751679 |
| 33 | low-density lipoprotein particle clearance (GO:0034383) | 3.37913470 |
| 34 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 3.34929120 |
| 35 | wound healing, spreading of epidermal cells (GO:0035313) | 3.29277880 |
| 36 | regulation of p38MAPK cascade (GO:1900744) | 3.25773818 |
| 37 | epithelial cell-cell adhesion (GO:0090136) | 3.23508736 |
| 38 | regulation of membrane protein ectodomain proteolysis (GO:0051043) | 3.19312264 |
| 39 | response to muramyl dipeptide (GO:0032495) | 3.17420690 |
| 40 | diol metabolic process (GO:0034311) | 3.16949936 |
| 41 | detection of bacterium (GO:0016045) | 3.16360207 |
| 42 | positive regulation of epidermis development (GO:0045684) | 3.15802435 |
| 43 | epithelial cell differentiation involved in prostate gland development (GO:0060742) | 3.13654800 |
| 44 | positive regulation of epidermal cell differentiation (GO:0045606) | 3.12446083 |
| 45 | chemical homeostasis within a tissue (GO:0048875) | 3.11265001 |
| 46 | cell-substrate junction assembly (GO:0007044) | 3.09845417 |
| 47 | regulation of ruffle assembly (GO:1900027) | 2.97007174 |
| 48 | detection of other organism (GO:0098543) | 2.94259489 |
| 49 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 2.92655895 |
| 50 | negative regulation of cell fate specification (GO:0009996) | 2.86158960 |
| 51 | atrioventricular valve morphogenesis (GO:0003181) | 2.85722187 |
| 52 | cell differentiation involved in embryonic placenta development (GO:0060706) | 2.83948817 |
| 53 | regulation of interleukin-8 secretion (GO:2000482) | 2.83838647 |
| 54 | positive regulation of interleukin-8 secretion (GO:2000484) | 2.83001672 |
| 55 | adhesion of symbiont to host (GO:0044406) | 2.82643389 |
| 56 | cyclooxygenase pathway (GO:0019371) | 2.80042319 |
| 57 | regulation of transforming growth factor beta1 production (GO:0032908) | 2.79839335 |
| 58 | regulation of keratinocyte proliferation (GO:0010837) | 2.76851809 |
| 59 | branching involved in labyrinthine layer morphogenesis (GO:0060670) | 2.69334990 |
| 60 | endothelial cell chemotaxis (GO:0035767) | 2.69272858 |
| 61 | cell adhesion mediated by integrin (GO:0033627) | 2.69044569 |
| 62 | eyelid development in camera-type eye (GO:0061029) | 2.67445278 |
| 63 | regulation of phospholipase A2 activity (GO:0032429) | 2.67176695 |
| 64 | dichotomous subdivision of an epithelial terminal unit (GO:0060600) | 2.66380458 |
| 65 | epithelial structure maintenance (GO:0010669) | 2.66331126 |
| 66 | regulation of epidermis development (GO:0045682) | 2.66043681 |
| 67 | intestinal cholesterol absorption (GO:0030299) | 2.65796251 |
| 68 | positive regulation of p38MAPK cascade (GO:1900745) | 2.61373971 |
| 69 | response to laminar fluid shear stress (GO:0034616) | 2.60643124 |
| 70 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 2.57858412 |
| 71 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.57858412 |
| 72 | modulation by symbiont of host immune response (GO:0052553) | 2.57858412 |
| 73 | positive regulation by symbiont of host defense response (GO:0052509) | 2.57858412 |
| 74 | modulation by symbiont of host defense response (GO:0052031) | 2.57858412 |
| 75 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.57858412 |
| 76 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 2.57667175 |
| 77 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.57147144 |
| 78 | regulation of branching involved in salivary gland morphogenesis (GO:0060693) | 2.56564399 |
| 79 | positive regulation of keratinocyte differentiation (GO:0045618) | 2.55835748 |
| 80 | adherens junction assembly (GO:0034333) | 2.53604873 |
| 81 | gland morphogenesis (GO:0022612) | 2.52879424 |
| 82 | regulation of Wnt signaling pathway involved in heart development (GO:0003307) | 2.52471183 |
| 83 | wound healing, spreading of cells (GO:0044319) | 2.51656092 |
| 84 | decidualization (GO:0046697) | 2.49661183 |
| 85 | intestinal absorption (GO:0050892) | 2.47817089 |
| 86 | response to peptidoglycan (GO:0032494) | 2.47293556 |
| 87 | linoleic acid metabolic process (GO:0043651) | 2.47163892 |
| 88 | negative regulation of fatty acid transport (GO:2000192) | 2.46613628 |
| 89 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 2.44871441 |
| 90 | negative regulation of interleukin-8 production (GO:0032717) | 2.44067464 |
| 91 | regulation of podosome assembly (GO:0071801) | 2.43847804 |
| 92 | CD4-positive, alpha-beta T cell differentiation involved in immune response (GO:0002294) | 2.43470185 |
| 93 | T-helper cell differentiation (GO:0042093) | 2.43470185 |
| 94 | positive regulation of hair cycle (GO:0042635) | 2.43463465 |
| 95 | positive regulation of hair follicle development (GO:0051798) | 2.43463465 |
| 96 | semaphorin-plexin signaling pathway (GO:0071526) | 2.43445364 |
| 97 | regulation of apoptotic process involved in morphogenesis (GO:1902337) | 2.43096812 |
| 98 | amyloid precursor protein catabolic process (GO:0042987) | 2.42983272 |
| 99 | planar cell polarity pathway involved in neural tube closure (GO:0090179) | 2.42547443 |
| 100 | positive regulation of tyrosine phosphorylation of Stat1 protein (GO:0042511) | 2.42023699 |
| 101 | negative regulation of viral release from host cell (GO:1902187) | 2.41546691 |
| 102 | cell-substrate adherens junction assembly (GO:0007045) | 2.41146495 |
| 103 | focal adhesion assembly (GO:0048041) | 2.41146495 |
| 104 | positive regulation of transcription from RNA polymerase II promoter in response to stress (GO:00360 | 2.40772250 |
| 105 | regulation of establishment of planar polarity involved in neural tube closure (GO:0090178) | 2.40599746 |
| 106 | regulation of hair follicle development (GO:0051797) | 2.40538705 |
| 107 | regulation of vitamin D biosynthetic process (GO:0060556) | 2.40288731 |
| 108 | endocytic recycling (GO:0032456) | 2.40119073 |
| 109 | trophoblast giant cell differentiation (GO:0060707) | 2.39975495 |
| 110 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.39058486 |
| 111 | regulation of vitamin metabolic process (GO:0030656) | 2.38862735 |
| 112 | negative regulation of cell fate commitment (GO:0010454) | 2.38716081 |
| 113 | regulation of cholesterol homeostasis (GO:2000188) | 2.38668717 |
| 114 | G-protein coupled purinergic nucleotide receptor signaling pathway (GO:0035589) | 2.36961518 |
| 115 | dorsal/ventral axis specification (GO:0009950) | 2.35309470 |
| 116 | COPI coating of Golgi vesicle (GO:0048205) | 2.35174453 |
| 117 | Golgi transport vesicle coating (GO:0048200) | 2.35174453 |
| 118 | barbed-end actin filament capping (GO:0051016) | 2.33802807 |
| 119 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.33762503 |
| 120 | NIK/NF-kappaB signaling (GO:0038061) | 2.32833465 |
| 121 | mannose metabolic process (GO:0006013) | 2.32392864 |
| 122 | stress fiber assembly (GO:0043149) | 2.31892430 |
| 123 | regulation of cell proliferation involved in kidney development (GO:1901722) | 2.31713626 |
| 124 | vascular endothelial growth factor receptor signaling pathway (GO:0048010) | 2.31138845 |
| 125 | maintenance of gastrointestinal epithelium (GO:0030277) | 2.31076748 |
| 126 | response to progesterone (GO:0032570) | 2.30633726 |
| 127 | lipoxygenase pathway (GO:0019372) | 2.29898717 |
| 128 | face development (GO:0060324) | 2.29719858 |
| 129 | branching involved in mammary gland duct morphogenesis (GO:0060444) | 2.29713395 |
| 130 | prostanoid metabolic process (GO:0006692) | 2.29652348 |
| 131 | prostaglandin metabolic process (GO:0006693) | 2.29652348 |
| 132 | positive regulation of antigen processing and presentation (GO:0002579) | 2.28956620 |
| 133 | cellular response to vascular endothelial growth factor stimulus (GO:0035924) | 2.27698169 |
| 134 | negative regulation of toll-like receptor signaling pathway (GO:0034122) | 2.26446982 |
| 135 | regulation of toll-like receptor 4 signaling pathway (GO:0034143) | 2.25857726 |
| 136 | positive regulation of cholesterol efflux (GO:0010875) | 2.25487324 |
| 137 | macrophage activation involved in immune response (GO:0002281) | 2.24951540 |
| 138 | positive regulation of chemokine secretion (GO:0090197) | 2.24413524 |
| 139 | regulation of early endosome to late endosome transport (GO:2000641) | 2.24272906 |
| 140 | regulation of integrin activation (GO:0033623) | 2.24212430 |
| 141 | positive regulation of extracellular matrix organization (GO:1903055) | 2.24197786 |
| 142 | response to type I interferon (GO:0034340) | 2.23138355 |
| 143 | type I interferon signaling pathway (GO:0060337) | 2.23084275 |
| 144 | cellular response to type I interferon (GO:0071357) | 2.23084275 |
| 145 | negative regulation of epidermal growth factor-activated receptor activity (GO:0007175) | 2.22666373 |
| 146 | negative regulation of interleukin-2 production (GO:0032703) | 2.22603395 |
| 147 | prostanoid biosynthetic process (GO:0046457) | 2.22550871 |
| 148 | prostaglandin biosynthetic process (GO:0001516) | 2.22550871 |
| 149 | regulation of heterotypic cell-cell adhesion (GO:0034114) | 2.22444314 |
| 150 | skin development (GO:0043588) | 2.22236946 |
| 151 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.22098886 |
| 152 | intermediate filament cytoskeleton organization (GO:0045104) | 2.21772523 |
| 153 | regulation of chemokine biosynthetic process (GO:0045073) | 2.21155137 |
| 154 | positive regulation of chemokine biosynthetic process (GO:0045080) | 2.19761610 |
| 155 | cell-cell junction maintenance (GO:0045217) | 2.18930680 |
| 156 | vascular endothelial growth factor signaling pathway (GO:0038084) | 2.16053520 |
| 157 | positive regulation of astrocyte differentiation (GO:0048711) | 2.15982750 |
| 158 | pinocytosis (GO:0006907) | 2.15766016 |
| 159 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.15534502 |
| 160 | embryo implantation (GO:0007566) | 2.13880806 |
| 161 | regulation of viral release from host cell (GO:1902186) | 2.12408072 |
| 162 | germinal center formation (GO:0002467) | 2.12228294 |
| 163 | cellular response to virus (GO:0098586) | 2.11857313 |
| 164 | ovulation (GO:0030728) | 2.10443851 |
| 165 | basement membrane organization (GO:0071711) | 2.10070532 |
| 166 | desmosome organization (GO:0002934) | 10.6477088 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 6.10258728 |
| 2 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 2.93349290 |
| 3 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 2.90007806 |
| 4 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 2.83455616 |
| 5 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 2.74475518 |
| 6 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.42034252 |
| 7 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 2.36718545 |
| 8 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 2.34435300 |
| 9 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 2.30891395 |
| 10 | * SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 2.30838921 |
| 11 | * SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 2.30838921 |
| 12 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 2.29431638 |
| 13 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.08480758 |
| 14 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 2.02546813 |
| 15 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 13.8847789 |
| 16 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.98116845 |
| 17 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.97044855 |
| 18 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.86344151 |
| 19 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.79739116 |
| 20 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.75678351 |
| 21 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.72628642 |
| 22 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.68229179 |
| 23 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.68174574 |
| 24 | * KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.67208420 |
| 25 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.64769107 |
| 26 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.60964798 |
| 27 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.57569856 |
| 28 | CJUN_26792858_Chip-Seq_BT549_Human | 1.57138524 |
| 29 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.56050826 |
| 30 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.52516734 |
| 31 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.49271918 |
| 32 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.49053612 |
| 33 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.47154889 |
| 34 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.46997555 |
| 35 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.46506705 |
| 36 | ATF3_27146783_Chip-Seq_COLON_Human | 1.42955178 |
| 37 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.42866493 |
| 38 | * KLF5_25053715_ChIP-Seq_YYC3_Human | 1.41603659 |
| 39 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.38901061 |
| 40 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.37501961 |
| 41 | GATA4_25053715_ChIP-Seq_YYC3_Human | 1.37294058 |
| 42 | * TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.35535272 |
| 43 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.34596280 |
| 44 | * GATA6_25053715_ChIP-Seq_YYC3_Human | 1.33080223 |
| 45 | * RACK7_27058665_Chip-Seq_MCF-7_Human | 1.32321833 |
| 46 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.28943004 |
| 47 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.28448217 |
| 48 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 1.26099536 |
| 49 | * FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.25482977 |
| 50 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.24381153 |
| 51 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 1.21325378 |
| 52 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 1.21325378 |
| 53 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 1.21325378 |
| 54 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.20869420 |
| 55 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.20750455 |
| 56 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.20232373 |
| 57 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.18990775 |
| 58 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.18832279 |
| 59 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.18715669 |
| 60 | UBF1/2_26484160_Chip-Seq_HMECs_Human | 1.18461894 |
| 61 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.17336198 |
| 62 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.16909638 |
| 63 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.16751967 |
| 64 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.14690190 |
| 65 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.13990639 |
| 66 | CREB1_26743006_Chip-Seq_LNCaP_Human | 1.13832767 |
| 67 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.12267111 |
| 68 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.11520191 |
| 69 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.11519062 |
| 70 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.11298697 |
| 71 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.11046413 |
| 72 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.08952030 |
| 73 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.08813873 |
| 74 | TP53_22127205_ChIP-Seq_IMR90_Human | 1.07071348 |
| 75 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.06180837 |
| 76 | TP53_16413492_ChIP-PET_HCT116_Human | 1.05753273 |
| 77 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.05339846 |
| 78 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.04478938 |
| 79 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.04478938 |
| 80 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.03660101 |
| 81 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.03592151 |
| 82 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.03378825 |
| 83 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.03271148 |
| 84 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.03205243 |
| 85 | * ZFP281_18757296_ChIP-ChIP_E14_Mouse | 0.99779299 |
| 86 | GATA1_19941826_ChIP-Seq_K562_Human | 0.97689442 |
| 87 | TP63_23658742_ChIP-Seq_EP156T_Human | 0.97575914 |
| 88 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 0.97479050 |
| 89 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 0.96861847 |
| 90 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.96059705 |
| 91 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.95379455 |
| 92 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 0.94395973 |
| 93 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 0.94230346 |
| 94 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 0.93701457 |
| 95 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.93069679 |
| 96 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 0.92135072 |
| 97 | RXR_22108803_ChIP-Seq_LS180_Human | 0.91911879 |
| 98 | P68_20966046_ChIP-Seq_HELA_Human | 0.89998066 |
| 99 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.89789154 |
| 100 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.88914876 |
| 101 | * TP63_22573176_ChIP-Seq_HFKS_Human | 0.88743439 |
| 102 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.86619990 |
| 103 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 0.86499143 |
| 104 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.85981961 |
| 105 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 0.85854279 |
| 106 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 0.85468015 |
| 107 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.84572881 |
| 108 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 0.81491842 |
| 109 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.80928051 |
| 110 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 0.80594950 |
| 111 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 0.76411479 |
| 112 | KDM2B_26808549_Chip-Seq_K562_Human | 0.76368517 |
| 113 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.76081068 |
| 114 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.76072181 |
| 115 | TCF3_18692474_ChIP-Seq_MEFs_Mouse | 0.75519331 |
| 116 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 0.75231326 |
| 117 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 0.74475999 |
| 118 | * P300_27058665_Chip-Seq_ZR-75-30cells_Human | 0.74458266 |
| 119 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.73215299 |
| 120 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 0.72717310 |
| 121 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 0.72140094 |
| 122 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.72116852 |
| 123 | TP63_19390658_ChIP-ChIP_HaCaT_Human | 0.71968463 |
| 124 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.71723494 |
| 125 | * BRD4_25478319_ChIP-Seq_HGPS_Human | 0.71322810 |
| 126 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.70972277 |
| 127 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 0.70712948 |
| 128 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 0.70489537 |
| 129 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 0.70251231 |
| 130 | ZIC3_20872845_ChIP-ChIP_MESCs_Mouse | 0.69362649 |
| 131 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.69144144 |
| 132 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 0.68727672 |
| 133 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 0.66727376 |
| 134 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.66540378 |
| 135 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 0.65516909 |
| 136 | TCF3_18692474_ChIP-Seq_MESCs_Mouse | 0.65198460 |
| 137 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 0.64742404 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003941_abnormal_skin_development | 5.03022608 |
| 2 | MP0002796_impaired_skin_barrier | 4.87349508 |
| 3 | MP0005275_abnormal_skin_tensile | 3.94294608 |
| 4 | MP0010234_abnormal_vibrissa_follicle | 3.75698770 |
| 5 | MP0002060_abnormal_skin_morphology | 3.35403355 |
| 6 | MP0000566_synostosis | 3.33942001 |
| 7 | MP0003453_abnormal_keratinocyte_physiol | 3.21650014 |
| 8 | MP0002254_reproductive_system_inflammat | 3.21648714 |
| 9 | MP0000383_abnormal_hair_follicle | 3.20074940 |
| 10 | MP0005501_abnormal_skin_physiology | 3.19644013 |
| 11 | MP0001216_abnormal_epidermal_layer | 3.00886787 |
| 12 | MP0003705_abnormal_hypodermis_morpholog | 2.91199964 |
| 13 | MP0002098_abnormal_vibrissa_morphology | 2.64229939 |
| 14 | MP0010678_abnormal_skin_adnexa | 2.62968114 |
| 15 | MP0004381_abnormal_hair_follicle | 2.60983751 |
| 16 | MP0000467_abnormal_esophagus_morphology | 2.50125154 |
| 17 | MP0010771_integument_phenotype | 2.34900343 |
| 18 | MP0003566_abnormal_cell_adhesion | 2.27787666 |
| 19 | MP0004947_skin_inflammation | 2.26852346 |
| 20 | MP0000579_abnormal_nail_morphology | 2.22958012 |
| 21 | MP0005058_abnormal_lysosome_morphology | 2.12038921 |
| 22 | MP0010352_gastrointestinal_tract_polyps | 2.07397669 |
| 23 | MP0000377_abnormal_hair_follicle | 1.99474597 |
| 24 | MP0000647_abnormal_sebaceous_gland | 1.91399311 |
| 25 | MP0005076_abnormal_cell_differentiation | 1.89549633 |
| 26 | MP0000762_abnormal_tongue_morphology | 1.73892015 |
| 27 | MP0004510_myositis | 1.71784172 |
| 28 | MP0005409_darkened_coat_color | 1.59998501 |
| 29 | MP0000427_abnormal_hair_cycle | 1.59996460 |
| 30 | MP0001191_abnormal_skin_condition | 1.59642608 |
| 31 | MP0009931_abnormal_skin_appearance | 1.55692223 |
| 32 | MP0004264_abnormal_extraembryonic_tissu | 1.55271108 |
| 33 | MP0005451_abnormal_body_composition | 1.52653810 |
| 34 | MP0009053_abnormal_anal_canal | 1.52323863 |
| 35 | MP0001958_emphysema | 1.44199864 |
| 36 | MP0002877_abnormal_melanocyte_morpholog | 1.39470156 |
| 37 | MP0005257_abnormal_intraocular_pressure | 1.39066805 |
| 38 | MP0001243_abnormal_dermal_layer | 1.38892854 |
| 39 | MP0002234_abnormal_pharynx_morphology | 1.38856209 |
| 40 | MP0002009_preneoplasia | 1.38643790 |
| 41 | MP0005666_abnormal_adipose_tissue | 1.37390411 |
| 42 | MP0000516_abnormal_urinary_system | 1.35953775 |
| 43 | MP0005367_renal/urinary_system_phenotyp | 1.35953775 |
| 44 | MP0004858_abnormal_nervous_system | 1.32769022 |
| 45 | MP0005023_abnormal_wound_healing | 1.32217240 |
| 46 | MP0001346_abnormal_lacrimal_gland | 1.31607628 |
| 47 | MP0001849_ear_inflammation | 1.30836455 |
| 48 | MP0005375_adipose_tissue_phenotype | 1.30749644 |
| 49 | MP0008260_abnormal_autophagy | 1.25013343 |
| 50 | MP0003436_decreased_susceptibility_to | 1.22928843 |
| 51 | MP0003075_altered_response_to | 1.22782580 |
| 52 | MP0008438_abnormal_cutaneous_collagen | 1.21331003 |
| 53 | MP0000367_abnormal_coat/_hair | 1.19789880 |
| 54 | MP0006082_CNS_inflammation | 1.17672857 |
| 55 | MP0010155_abnormal_intestine_physiology | 1.16407154 |
| 56 | MP0008004_abnormal_stomach_pH | 1.15687612 |
| 57 | MP0005164_abnormal_response_to | 1.14762765 |
| 58 | MP0003300_gastrointestinal_ulcer | 1.14414930 |
| 59 | MP0004185_abnormal_adipocyte_glucose | 1.14008355 |
| 60 | MP0001851_eye_inflammation | 1.12942149 |
| 61 | MP0002332_abnormal_exercise_endurance | 1.11780513 |
| 62 | MP0000678_abnormal_parathyroid_gland | 1.10497938 |
| 63 | MP0005508_abnormal_skeleton_morphology | 1.06302301 |
| 64 | MP0002139_abnormal_hepatobiliary_system | 1.05838758 |
| 65 | MP0003279_aneurysm | 1.05398858 |
| 66 | MP0000627_abnormal_mammary_gland | 1.02386674 |
| 67 | MP0000003_abnormal_adipose_tissue | 0.99939433 |
| 68 | MP0005166_decreased_susceptibility_to | 0.98191896 |
| 69 | MP0010030_abnormal_orbit_morphology | 0.96802154 |
| 70 | MP0002006_tumorigenesis | 0.95338730 |
| 71 | MP0003303_peritoneal_inflammation | 0.94552271 |
| 72 | MP0005025_abnormal_response_to | 0.92301447 |
| 73 | MP0003329_amyloid_beta_deposits | 0.91572399 |
| 74 | MP0000767_abnormal_smooth_muscle | 0.90780709 |
| 75 | MP0005083_abnormal_biliary_tract | 0.88596232 |
| 76 | MP0002896_abnormal_bone_mineralization | 0.88048306 |
| 77 | MP0000343_altered_response_to | 0.86684217 |
| 78 | MP0002166_altered_tumor_susceptibility | 0.85774944 |
| 79 | MP0000537_abnormal_urethra_morphology | 0.85080075 |
| 80 | MP0000465_gastrointestinal_hemorrhage | 0.84967997 |
| 81 | MP0002419_abnormal_innate_immunity | 0.84552082 |
| 82 | MP0001542_abnormal_bone_strength | 0.84058352 |
| 83 | MP0002132_abnormal_respiratory_system | 0.83685766 |
| 84 | MP0000604_amyloidosis | 0.83297358 |
| 85 | MP0005165_increased_susceptibility_to | 0.82648891 |
| 86 | MP0003315_abnormal_perineum_morphology | 0.82276762 |
| 87 | MP0005390_skeleton_phenotype | 0.81505934 |
| 88 | MP0004019_abnormal_vitamin_homeostasis | 0.81118416 |
| 89 | MP0010368_abnormal_lymphatic_system | 0.80457014 |
| 90 | MP0002277_abnormal_respiratory_mucosa | 0.80012715 |
| 91 | MP0003950_abnormal_plasma_membrane | 0.79127579 |
| 92 | MP0000858_altered_metastatic_potential | 0.78730904 |
| 93 | MP0004782_abnormal_surfactant_physiolog | 0.78589601 |
| 94 | MP0003763_abnormal_thymus_physiology | 0.77970745 |
| 95 | MP0002111_abnormal_tail_morphology | 0.77445622 |
| 96 | MP0001666_abnormal_nutrient_absorption | 0.76621919 |
| 97 | MP0001340_abnormal_eyelid_morphology | 0.74505542 |
| 98 | MP0005503_abnormal_tendon_morphology | 0.74131071 |
| 99 | MP0003191_abnormal_cellular_cholesterol | 0.72511566 |
| 100 | MP0000490_abnormal_crypts_of | 0.71751053 |
| 101 | MP0002089_abnormal_postnatal_growth/wei | 0.71723797 |
| 102 | MP0002148_abnormal_hypersensitivity_rea | 0.71718279 |
| 103 | MP0003828_pulmonary_edema | 0.71405371 |
| 104 | MP0009764_decreased_sensitivity_to | 0.71399263 |
| 105 | MP0000477_abnormal_intestine_morphology | 0.70718458 |
| 106 | MP0003866_abnormal_defecation | 0.69826393 |
| 107 | MP0002933_joint_inflammation | 0.68386292 |
| 108 | MP0000249_abnormal_blood_vessel | 0.68240081 |
| 109 | MP0004272_abnormal_basement_membrane | 0.67587952 |
| 110 | MP0000750_abnormal_muscle_regeneration | 0.67488216 |
| 111 | MP0009333_abnormal_splenocyte_physiolog | 0.67032824 |
| 112 | MP0004883_abnormal_blood_vessel | 0.66566820 |
| 113 | MP0009278_abnormal_bone_marrow | 0.66486489 |
| 114 | MP0005397_hematopoietic_system_phenotyp | 0.65888815 |
| 115 | MP0001545_abnormal_hematopoietic_system | 0.65888815 |
| 116 | MP0003045_fibrosis | 0.65349885 |
| 117 | MP0005595_abnormal_vascular_smooth | 0.65164792 |
| 118 | MP0003448_altered_tumor_morphology | 0.64488901 |
| 119 | MP0003091_abnormal_cell_migration | 0.62470563 |
| 120 | MP0000470_abnormal_stomach_morphology | 0.62356478 |
| 121 | MP0001533_abnormal_skeleton_physiology | 0.59465683 |
| 122 | MP0000733_abnormal_muscle_development | 0.59355166 |
| 123 | MP0000538_abnormal_urinary_bladder | 0.59243836 |
| 124 | MP0002998_abnormal_bone_remodeling | 0.59047260 |
| 125 | MP0001790_abnormal_immune_system | 0.58404361 |
| 126 | MP0005387_immune_system_phenotype | 0.58404361 |
| 127 | MP0002697_abnormal_eye_size | 0.58395761 |
| 128 | MP0003724_increased_susceptibility_to | 0.57918769 |
| 129 | MP0003755_abnormal_palate_morphology | 0.57311644 |
| 130 | MP0002177_abnormal_outer_ear | 0.57239510 |
| 131 | MP0000432_abnormal_head_morphology | 0.56775770 |
| 132 | MP0009840_abnormal_foam_cell | 0.56562820 |
| 133 | MP0006054_spinal_hemorrhage | 0.53442282 |
| 134 | MP0008789_abnormal_olfactory_epithelium | 0.52814880 |
| 135 | MP0000613_abnormal_salivary_gland | 0.50824799 |
| 136 | MP0009785_altered_susceptibility_to | 0.45369421 |
| 137 | MP0005000_abnormal_immune_tolerance | 0.44193659 |
| 138 | MP0001800_abnormal_humoral_immune | 0.44093253 |
| 139 | MP0002452_abnormal_antigen_presenting | 0.43451242 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Milia (HP:0001056) | 6.19820527 |
| 2 | Lip pit (HP:0100267) | 5.96036578 |
| 3 | Plantar hyperkeratosis (HP:0007556) | 5.41843973 |
| 4 | Thick nail (HP:0001805) | 4.95593823 |
| 5 | Right ventricular cardiomyopathy (HP:0011663) | 4.78396222 |
| 6 | Hypotrichosis (HP:0001006) | 4.73377840 |
| 7 | Palmoplantar hyperkeratosis (HP:0000972) | 4.61658598 |
| 8 | Fragile nails (HP:0001808) | 4.58193036 |
| 9 | Palmar hyperkeratosis (HP:0010765) | 4.38935642 |
| 10 | Alopecia of scalp (HP:0002293) | 4.30464255 |
| 11 | Onycholysis (HP:0001806) | 4.19967219 |
| 12 | Atrophic scars (HP:0001075) | 4.19185880 |
| 13 | Popliteal pterygium (HP:0009756) | 4.02221985 |
| 14 | Woolly hair (HP:0002224) | 3.87109777 |
| 15 | Parakeratosis (HP:0001036) | 3.57033211 |
| 16 | Nail dystrophy (HP:0008404) | 3.47929863 |
| 17 | Hypoplastic labia majora (HP:0000059) | 3.43851453 |
| 18 | Abnormal blistering of the skin (HP:0008066) | 3.37810175 |
| 19 | Pili torti (HP:0003777) | 3.23721277 |
| 20 | Pustule (HP:0200039) | 3.19559823 |
| 21 | Interstitial pulmonary disease (HP:0006530) | 3.18027370 |
| 22 | Ectropion (HP:0000656) | 3.13851504 |
| 23 | Abnormality of the labia majora (HP:0012881) | 3.12177965 |
| 24 | Abnormality of the neuromuscular junction (HP:0003398) | 3.10681886 |
| 25 | Fatigable weakness (HP:0003473) | 3.10681886 |
| 26 | Congenital ichthyosiform erythroderma (HP:0007431) | 3.09827800 |
| 27 | Distal lower limb muscle weakness (HP:0009053) | 3.04931779 |
| 28 | Thin bony cortex (HP:0002753) | 2.91828619 |
| 29 | Increased IgE level (HP:0003212) | 2.88947570 |
| 30 | Abnormality of nail color (HP:0100643) | 2.83343041 |
| 31 | Hypohidrosis (HP:0000966) | 2.82290312 |
| 32 | Oligodontia (HP:0000677) | 2.81927929 |
| 33 | Malnutrition (HP:0004395) | 2.80027259 |
| 34 | Natal tooth (HP:0000695) | 2.72462121 |
| 35 | Protrusio acetabuli (HP:0003179) | 2.71873883 |
| 36 | Increased connective tissue (HP:0009025) | 2.69386926 |
| 37 | Axonal loss (HP:0003447) | 2.68028139 |
| 38 | Erythema (HP:0010783) | 2.66771805 |
| 39 | Systemic lupus erythematosus (HP:0002725) | 2.66514071 |
| 40 | Abnormality of the salivary glands (HP:0010286) | 2.66250518 |
| 41 | Pterygium (HP:0001059) | 2.64998306 |
| 42 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.62039338 |
| 43 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.62039338 |
| 44 | Abnormality of glycolipid metabolism (HP:0010969) | 2.62039338 |
| 45 | Corneal erosion (HP:0200020) | 2.60208548 |
| 46 | Fragile skin (HP:0001030) | 2.60133804 |
| 47 | Gangrene (HP:0100758) | 2.59197522 |
| 48 | Ridged nail (HP:0001807) | 2.57190576 |
| 49 | Aplasia cutis congenita (HP:0001057) | 2.55260038 |
| 50 | Premature rupture of membranes (HP:0001788) | 2.54880754 |
| 51 | Cervical subluxation (HP:0003308) | 2.54602970 |
| 52 | Hypoplasia of dental enamel (HP:0006297) | 2.53211489 |
| 53 | Abnormality of the distal phalanges of the toes (HP:0010182) | 2.52922755 |
| 54 | Neurofibrillary tangles (HP:0002185) | 2.50532356 |
| 55 | Erythroderma (HP:0001019) | 2.48840583 |
| 56 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 2.45524370 |
| 57 | Sparse eyelashes (HP:0000653) | 2.43924125 |
| 58 | Dysostosis multiplex (HP:0000943) | 2.34518141 |
| 59 | Sparse scalp hair (HP:0002209) | 2.34281257 |
| 60 | Short nail (HP:0001799) | 2.30828893 |
| 61 | Advanced eruption of teeth (HP:0006288) | 2.25487611 |
| 62 | Distal lower limb amyotrophy (HP:0008944) | 2.22982862 |
| 63 | Abnormality of complement system (HP:0005339) | 2.21575347 |
| 64 | Curly hair (HP:0002212) | 2.20554289 |
| 65 | Orchitis (HP:0100796) | 2.20149942 |
| 66 | Upper limb muscle weakness (HP:0003484) | 2.19028881 |
| 67 | Vertebral compression fractures (HP:0002953) | 2.16925724 |
| 68 | Pruritus (HP:0000989) | 2.11014989 |
| 69 | Abnormality of the gastric mucosa (HP:0004295) | 2.09388875 |
| 70 | Cerebral inclusion bodies (HP:0100314) | 2.09121740 |
| 71 | Broad face (HP:0000283) | 2.08562744 |
| 72 | Complement deficiency (HP:0004431) | 2.06987719 |
| 73 | Flat acetabular roof (HP:0003180) | 2.06892844 |
| 74 | Anhidrosis (HP:0000970) | 2.05701820 |
| 75 | Glomerulonephritis (HP:0000099) | 2.05628644 |
| 76 | Hyperparathyroidism (HP:0000843) | 2.04781917 |
| 77 | Blepharitis (HP:0000498) | 2.03600412 |
| 78 | Urethral obstruction (HP:0000796) | 2.02749042 |
| 79 | Acanthosis nigricans (HP:0000956) | 2.02717411 |
| 80 | Skin pits (HP:0100276) | 2.02456228 |
| 81 | Hemorrhage of the eye (HP:0011885) | 2.00856661 |
| 82 | Loss of speech (HP:0002371) | 2.00349911 |
| 83 | Premature loss of primary teeth (HP:0006323) | 1.98432768 |
| 84 | Ulnar bowing (HP:0003031) | 1.98310632 |
| 85 | Peritonitis (HP:0002586) | 1.97110317 |
| 86 | Labial hypoplasia (HP:0000066) | 1.95330833 |
| 87 | Segmental peripheral demyelination/remyelination (HP:0003481) | 1.94651898 |
| 88 | Achilles tendon contracture (HP:0001771) | 1.93714164 |
| 89 | Abnormality of the nasal mucosa (HP:0000433) | 1.93628117 |
| 90 | Nuclear cataract (HP:0100018) | 1.93505676 |
| 91 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.91382798 |
| 92 | Mucopolysacchariduria (HP:0008155) | 1.91382798 |
| 93 | Abnormal hair laboratory examination (HP:0003328) | 1.90406601 |
| 94 | Abnormality of the labia (HP:0000058) | 1.90355137 |
| 95 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.90163242 |
| 96 | Abnormality of polysaccharide metabolism (HP:0011012) | 1.90163242 |
| 97 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.90163242 |
| 98 | Amyloidosis (HP:0011034) | 1.90051112 |
| 99 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 1.89417646 |
| 100 | Ureteral duplication (HP:0000073) | 1.89134979 |
| 101 | Dehydration (HP:0001944) | 1.88370335 |
| 102 | Ventricular tachycardia (HP:0004756) | 1.88133990 |
| 103 | Myocardial infarction (HP:0001658) | 1.86013656 |
| 104 | Follicular hyperkeratosis (HP:0007502) | 1.84496563 |
| 105 | Deep venous thrombosis (HP:0002625) | 1.84357997 |
| 106 | Aneurysm (HP:0002617) | 1.82487432 |
| 107 | Distal upper limb amyotrophy (HP:0007149) | 1.82273241 |
| 108 | Upper limb amyotrophy (HP:0009129) | 1.82273241 |
| 109 | Abnormality of the Achilles tendon (HP:0005109) | 1.81253181 |
| 110 | Hypoplastic female external genitalia (HP:0012815) | 1.80989413 |
| 111 | Skin ulcer (HP:0200042) | 1.78594161 |
| 112 | Vacuolated lymphocytes (HP:0001922) | 1.78117201 |
| 113 | Retrobulbar optic neuritis (HP:0100654) | 1.77722851 |
| 114 | Optic neuritis (HP:0100653) | 1.77722851 |
| 115 | Abnormality of macrophages (HP:0004311) | 1.77240494 |
| 116 | Obstructive sleep apnea (HP:0002870) | 1.76874622 |
| 117 | Vascular tortuosity (HP:0004948) | 1.76210047 |
| 118 | Palmoplantar keratoderma (HP:0000982) | 1.75403866 |
| 119 | Nephritis (HP:0000123) | 1.74944698 |
| 120 | Increased cerebral lipofuscin (HP:0011813) | 1.73615782 |
| 121 | Asymmetric septal hypertrophy (HP:0001670) | 1.73181018 |
| 122 | Down-sloping shoulders (HP:0200021) | 1.72567985 |
| 123 | Arterial tortuosity (HP:0005116) | 1.71961185 |
| 124 | Oral leukoplakia (HP:0002745) | 1.71383979 |
| 125 | Blue sclerae (HP:0000592) | 1.70123090 |
| 126 | Elevated erythrocyte sedimentation rate (HP:0003565) | 1.69426171 |
| 127 | Nasal polyposis (HP:0100582) | 1.69386571 |
| 128 | Myositis (HP:0100614) | 1.68079679 |
| 129 | Absent eyebrow (HP:0002223) | 1.67065476 |
| 130 | Mitral regurgitation (HP:0001653) | 1.66861698 |
| 131 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 1.66786543 |
| 132 | Osteolytic defects of the hand bones (HP:0009699) | 1.66786543 |
| 133 | Cheilitis (HP:0100825) | 1.66262818 |
| 134 | Difficulty climbing stairs (HP:0003551) | 1.65819548 |
| 135 | Aortic aneurysm (HP:0004942) | 1.65499070 |
| 136 | Aortic dissection (HP:0002647) | 1.65300374 |
| 137 | Mildly elevated creatine phosphokinase (HP:0008180) | 1.61422593 |
| 138 | Conjunctival hamartoma (HP:0100780) | 1.61228645 |
| 139 | Hypodontia (HP:0000668) | 1.59362054 |
| 140 | Trismus (HP:0000211) | 1.59280532 |
| 141 | Ureteral obstruction (HP:0006000) | 1.57866855 |
| 142 | Dry skin (HP:0000958) | 1.56785195 |
| 143 | Eczematoid dermatitis (HP:0000976) | 1.56607806 |
| 144 | Abnormality of the nasal septum (HP:0000419) | 1.56257595 |
| 145 | Submucous cleft hard palate (HP:0000176) | 1.55943712 |
| 146 | Entropion (HP:0000621) | 1.55083779 |
| 147 | Cerebral aneurysm (HP:0004944) | 1.51775263 |
| 148 | Soft skin (HP:0000977) | 1.51495026 |
| 149 | Polygenic inheritance (HP:0010982) | 1.49827781 |
| 150 | Rectal prolapse (HP:0002035) | 1.49421059 |
| 151 | Prostate neoplasm (HP:0100787) | 1.49204859 |
| 152 | Shallow orbits (HP:0000586) | 1.48707865 |
| 153 | Periodontitis (HP:0000704) | 1.48452879 |
| 154 | Dilatation of the ascending aorta (HP:0005111) | 1.48439849 |
| 155 | Hypoplasia of the uterus (HP:0000013) | 1.47632029 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EPHA2 | 4.98972857 |
| 2 | MAP3K3 | 4.56472928 |
| 3 | MST1R | 3.51949136 |
| 4 | LATS1 | 2.80770615 |
| 5 | MAPKAPK3 | 2.49029815 |
| 6 | MAP3K14 | 2.47141286 |
| 7 | PRPF4B | 2.41805288 |
| 8 | SIK1 | 2.37644774 |
| 9 | ERN1 | 2.35628668 |
| 10 | MST4 | 2.35280441 |
| 11 | EPHB2 | 2.02527440 |
| 12 | RPS6KA4 | 2.00315266 |
| 13 | RPS6KB2 | 1.98645497 |
| 14 | FRK | 1.96692136 |
| 15 | FGFR4 | 1.90370257 |
| 16 | EEF2K | 1.85229597 |
| 17 | TGFBR2 | 1.84700089 |
| 18 | MAP3K2 | 1.77075232 |
| 19 | SMG1 | 1.76067400 |
| 20 | NME2 | 1.73645213 |
| 21 | CDK12 | 1.64388182 |
| 22 | FER | 1.60287338 |
| 23 | STK10 | 1.56983365 |
| 24 | ICK | 1.52941529 |
| 25 | TBK1 | 1.52915382 |
| 26 | EPHA3 | 1.52697650 |
| 27 | CDC42BPA | 1.51118937 |
| 28 | CHUK | 1.48169538 |
| 29 | IKBKE | 1.47803365 |
| 30 | TRPM7 | 1.47268949 |
| 31 | PIM2 | 1.44580064 |
| 32 | IKBKB | 1.43405714 |
| 33 | MAP2K3 | 1.36037952 |
| 34 | TAOK1 | 1.35503892 |
| 35 | TYK2 | 1.31729339 |
| 36 | IRAK3 | 1.27040698 |
| 37 | DMPK | 1.25401674 |
| 38 | PTK6 | 1.25303054 |
| 39 | PAK4 | 1.23925177 |
| 40 | MAP3K6 | 1.19310010 |
| 41 | PKN2 | 1.19037649 |
| 42 | RIPK1 | 1.16913032 |
| 43 | MET | 1.16705131 |
| 44 | MAP3K7 | 1.15615002 |
| 45 | TESK1 | 1.14863139 |
| 46 | NUAK1 | 1.14823159 |
| 47 | MAPK15 | 1.14127991 |
| 48 | EIF2AK2 | 1.03909579 |
| 49 | FGFR3 | 1.02146435 |
| 50 | TAOK2 | 1.01835378 |
| 51 | STK38L | 1.00413823 |
| 52 | PRKD2 | 0.99108684 |
| 53 | MAP3K10 | 0.97739084 |
| 54 | STK3 | 0.97392870 |
| 55 | ERBB3 | 0.96712796 |
| 56 | LMTK2 | 0.94893829 |
| 57 | STK38 | 0.88721307 |
| 58 | RPS6KA2 | 0.87854723 |
| 59 | MAP2K2 | 0.87667877 |
| 60 | MARK2 | 0.87311984 |
| 61 | PIM1 | 0.87161826 |
| 62 | NLK | 0.85200493 |
| 63 | JAK3 | 0.84676903 |
| 64 | MAP3K11 | 0.84119783 |
| 65 | ABL2 | 0.82007763 |
| 66 | BLK | 0.80325660 |
| 67 | MAPKAPK2 | 0.79053235 |
| 68 | EPHB1 | 0.79012520 |
| 69 | PTK2 | 0.77494355 |
| 70 | MAP3K13 | 0.77235436 |
| 71 | CDK3 | 0.75865185 |
| 72 | CDK6 | 0.75436200 |
| 73 | ARAF | 0.74143006 |
| 74 | ZAK | 0.71256303 |
| 75 | ZAP70 | 0.70403444 |
| 76 | MATK | 0.69661940 |
| 77 | PDGFRB | 0.69386301 |
| 78 | PRKCI | 0.68860457 |
| 79 | MAP3K9 | 0.68291091 |
| 80 | TSSK6 | 0.66939869 |
| 81 | TRIB3 | 0.66597512 |
| 82 | NTRK1 | 0.66555596 |
| 83 | LATS2 | 0.66290416 |
| 84 | PDPK1 | 0.66188783 |
| 85 | IRAK1 | 0.66082122 |
| 86 | JAK1 | 0.65950990 |
| 87 | IRAK2 | 0.65308524 |
| 88 | FGFR2 | 0.64990667 |
| 89 | RPS6KC1 | 0.64507497 |
| 90 | RPS6KL1 | 0.64507497 |
| 91 | GRK7 | 0.63847927 |
| 92 | IRAK4 | 0.62981128 |
| 93 | STK24 | 0.62738927 |
| 94 | MYLK | 0.60085319 |
| 95 | GSK3A | 0.59176432 |
| 96 | BMX | 0.58263649 |
| 97 | CDK9 | 0.57513818 |
| 98 | ERBB2 | 0.57436711 |
| 99 | ERBB4 | 0.56689956 |
| 100 | CAMK1D | 0.56477220 |
| 101 | PDGFRA | 0.55183077 |
| 102 | BMPR1B | 0.54878753 |
| 103 | LRRK2 | 0.54365832 |
| 104 | GRK1 | 0.54169572 |
| 105 | TTN | 0.53999065 |
| 106 | ITK | 0.53150509 |
| 107 | AKT3 | 0.52275229 |
| 108 | DAPK3 | 0.51146920 |
| 109 | MTOR | 0.50592928 |
| 110 | RIPK4 | 0.50380699 |
| 111 | NME1 | 0.49606516 |
| 112 | MAP3K1 | 0.49400467 |
| 113 | MAP4K1 | 0.49022993 |
| 114 | FGR | 0.47968013 |
| 115 | KSR2 | 0.45737668 |
| 116 | RPS6KA6 | 0.44390894 |
| 117 | MAPK4 | 0.42652621 |
| 118 | AURKB | 0.42551725 |
| 119 | HIPK2 | 0.42037449 |
| 120 | DDR2 | 0.41475736 |
| 121 | MAPKAPK5 | 0.41026459 |
| 122 | MARK3 | 0.40830156 |
| 123 | RPS6KA1 | 0.40613390 |
| 124 | CSK | 0.39621613 |
| 125 | JAK2 | 0.39321927 |
| 126 | MAPK7 | 0.39248220 |
| 127 | MAP3K5 | 0.39202571 |
| 128 | HCK | 0.39121471 |
| 129 | MAP3K8 | 0.38531407 |
| 130 | PIK3CG | 0.38178390 |
| 131 | PAK2 | 0.37611452 |
| 132 | RET | 0.37314828 |
| 133 | TXK | 0.36424303 |
| 134 | ABL1 | 0.35550928 |
| 135 | MAP2K6 | 0.35496271 |
| 136 | PRKAA2 | 0.34558617 |
| 137 | MOS | 0.34549060 |
| 138 | MAP2K1 | 0.34517547 |
| 139 | SGK3 | 0.33665273 |
| 140 | SIK3 | 0.33249876 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Other glycan degradation_Homo sapiens_hsa00511 | 2.34793942 |
| 2 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.93474241 |
| 3 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 1.91624882 |
| 4 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.87288723 |
| 5 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.84884318 |
| 6 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.79441441 |
| 7 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.79306614 |
| 8 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.77768887 |
| 9 | ECM-receptor interaction_Homo sapiens_hsa04512 | 1.77089753 |
| 10 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.70972265 |
| 11 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.70688714 |
| 12 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.67866132 |
| 13 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.66450926 |
| 14 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.64732880 |
| 15 | Small cell lung cancer_Homo sapiens_hsa05222 | 1.62670260 |
| 16 | Prion diseases_Homo sapiens_hsa05020 | 1.62215988 |
| 17 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.61173070 |
| 18 | Legionellosis_Homo sapiens_hsa05134 | 1.56438781 |
| 19 | p53 signaling pathway_Homo sapiens_hsa04115 | 1.53016042 |
| 20 | Amoebiasis_Homo sapiens_hsa05146 | 1.52130044 |
| 21 | Adherens junction_Homo sapiens_hsa04520 | 1.49997598 |
| 22 | Leishmaniasis_Homo sapiens_hsa05140 | 1.49291250 |
| 23 | Malaria_Homo sapiens_hsa05144 | 1.48419246 |
| 24 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.45817807 |
| 25 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 1.45100040 |
| 26 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.44917139 |
| 27 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.44702449 |
| 28 | Mineral absorption_Homo sapiens_hsa04978 | 1.40902498 |
| 29 | Basal cell carcinoma_Homo sapiens_hsa05217 | 1.34723287 |
| 30 | Lysosome_Homo sapiens_hsa04142 | 1.32606812 |
| 31 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.32525622 |
| 32 | Hippo signaling pathway_Homo sapiens_hsa04390 | 1.30270195 |
| 33 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.27146128 |
| 34 | Hepatitis C_Homo sapiens_hsa05160 | 1.26967802 |
| 35 | Influenza A_Homo sapiens_hsa05164 | 1.24992935 |
| 36 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 1.24426200 |
| 37 | Bladder cancer_Homo sapiens_hsa05219 | 1.23940184 |
| 38 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.23875560 |
| 39 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.21697808 |
| 40 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.18632805 |
| 41 | Apoptosis_Homo sapiens_hsa04210 | 1.18380808 |
| 42 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 1.17048924 |
| 43 | Pertussis_Homo sapiens_hsa05133 | 1.15903341 |
| 44 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 1.14710753 |
| 45 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.13756322 |
| 46 | ABC transporters_Homo sapiens_hsa02010 | 1.12049931 |
| 47 | Protein digestion and absorption_Homo sapiens_hsa04974 | 1.08378969 |
| 48 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.07983517 |
| 49 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.07527501 |
| 50 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.05976492 |
| 51 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.04875645 |
| 52 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 1.03676162 |
| 53 | Galactose metabolism_Homo sapiens_hsa00052 | 1.02801884 |
| 54 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.99374861 |
| 55 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.98484473 |
| 56 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.98083045 |
| 57 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.96544207 |
| 58 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.96467495 |
| 59 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.94810948 |
| 60 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.92721368 |
| 61 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.92232063 |
| 62 | Insulin resistance_Homo sapiens_hsa04931 | 0.91331012 |
| 63 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.90638537 |
| 64 | Tight junction_Homo sapiens_hsa04530 | 0.90106048 |
| 65 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.89293832 |
| 66 | Tuberculosis_Homo sapiens_hsa05152 | 0.88884446 |
| 67 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.88856635 |
| 68 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.86475919 |
| 69 | HTLV-I infection_Homo sapiens_hsa05166 | 0.86269332 |
| 70 | Measles_Homo sapiens_hsa05162 | 0.84859417 |
| 71 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.84755604 |
| 72 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.83641582 |
| 73 | Shigellosis_Homo sapiens_hsa05131 | 0.82258177 |
| 74 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.81372424 |
| 75 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.80975544 |
| 76 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.80547859 |
| 77 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.80054178 |
| 78 | Histidine metabolism_Homo sapiens_hsa00340 | 0.79829188 |
| 79 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.79417647 |
| 80 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.78956399 |
| 81 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.78893497 |
| 82 | Salmonella infection_Homo sapiens_hsa05132 | 0.78512175 |
| 83 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.77885085 |
| 84 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.77688283 |
| 85 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.77615324 |
| 86 | Focal adhesion_Homo sapiens_hsa04510 | 0.77469589 |
| 87 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.77095334 |
| 88 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.76573737 |
| 89 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.76273741 |
| 90 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.76254769 |
| 91 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.75847512 |
| 92 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.75381798 |
| 93 | Prostate cancer_Homo sapiens_hsa05215 | 0.71892513 |
| 94 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.71777070 |
| 95 | Hepatitis B_Homo sapiens_hsa05161 | 0.71322087 |
| 96 | Endocytosis_Homo sapiens_hsa04144 | 0.69274090 |
| 97 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.68898563 |
| 98 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.67615799 |
| 99 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.66988185 |
| 100 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.66001147 |
| 101 | Circadian rhythm_Homo sapiens_hsa04710 | 0.65603309 |
| 102 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.65559035 |
| 103 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.64926963 |
| 104 | Pathways in cancer_Homo sapiens_hsa05200 | 0.64044852 |
| 105 | Endometrial cancer_Homo sapiens_hsa05213 | 0.63418581 |
| 106 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.62853483 |
| 107 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.61082443 |
| 108 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.60735744 |
| 109 | Retinol metabolism_Homo sapiens_hsa00830 | 0.60319506 |
| 110 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.59200421 |
| 111 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.59031809 |
| 112 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.58858215 |
| 113 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.58623602 |
| 114 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.58038334 |
| 115 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.57856217 |
| 116 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.57182472 |
| 117 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.56742736 |
| 118 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.53427209 |
| 119 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.53161411 |
| 120 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.51565147 |
| 121 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.50394726 |
| 122 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.50176339 |
| 123 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.49342562 |
| 124 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.48980636 |
| 125 | Thyroid cancer_Homo sapiens_hsa05216 | 0.48660935 |
| 126 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.48501366 |
| 127 | Glioma_Homo sapiens_hsa05214 | 0.48259839 |
| 128 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.47910734 |
| 129 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.46821101 |
| 130 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.46428477 |
| 131 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.45856051 |
| 132 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.45416048 |
| 133 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.45309663 |
| 134 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.44943616 |
| 135 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.44942385 |
| 136 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.44582755 |
| 137 | Platelet activation_Homo sapiens_hsa04611 | 0.44157110 |
| 138 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.43443480 |

